36 completed, 12 unknown, 8 recruiting, 4 active not recruiting. 68 Phase 1, 23 Phase 2.
Follow Mild Cognitive Impairment: new trials by email Literature Review of Mild Cognitive Impairment trials Research Report on Mild Cognitive Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) 18F-PF974, 18F-florbetaben - Alzheimer s Disease, Mild Cognitive Impairment | Phase 1 | Recruiting | National Institute of Mental Health (NIMH) | 90 | 2026-11-23 | 2026-11-18 |
| 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients 2-hydroxybenzylamine acetate, Placebo - Alzheimer Disease, Mild Cognitive Impairment | Phase 1 / Phase 2 | Not yet recruiting | MTI Biotech Inc | 48 | 2026-09-01 | 2026-09-24 |
| Sense4Safety Intervention Sense4Safety - Mild Cognitive Impairment | Phase 1 / Phase 2 | Recruiting | University of Pennsylvania | 200 | 2026-02-19 | 2026-03-19 |
| Epileptic Hippocampus in Alzheimer's Disease Brivaracetam - Alzheimer Disease, Mild Cognitive Impairment | Phase 1 / Phase 2 | Not yet recruiting | University of California, Los Angeles | 25 | 2026-01-01 | 2026-01-27 |
| The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment Metfomin - Mild Cognitive Impairment, Overweight or Obesity | Phase 1 / Phase 2 | Recruiting | Fudan University | 54 | 2025-09-01 | 2026-02-09 |
| TREAD: Time Restricted Eating Intervention for Alzheimer's Disease Time-restricted eating - Mild Cognitive Impairment, Alzheimer Disease | Phase 1 | Recruiting | University of California, San Diego | 60 | 2025-04-23 | 2026-05-26 |
| Phenserine on the Alzheimer's Treatment Horizon, Study 1 Phenserine, Donepezil (AriceptĀ®) - Alzheimer Disease, Mild Cognitive Impairment | Phase 1 | Completed | Helse Stavanger HF | 16 | 2025-02-01 | 2026-05-04 |
| Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI Sublingual administration, Electroencephalography, Biochemical mesurements - Mild Cognitive Impairment, Anxiety State | Phase 1 / Phase 2 | Completed | Biomind Labs Inc. | 20 | 2024-12-15 | 2025-04-09 |
| CogT pSOPT Intervention Study pSOPT, MLA - Mild Cognitive Impairment, Subjective Cognitive Impairment | Phase 1 | Completed | Stanford University | 50 | 2024-01-12 | 2026-11-18 |
| Effects Multimodal Mind and Body Approach for MCI Experimental: A computer-based multimodal mind and body approach (cbMMBA), A standard cognitive training group - Mild Cognitive Impairment | Phase 1 | Completed | Massachusetts General Hospital | 32 | 2023-12-11 | 2026-03-09 |
| rTMS in Older Adults With MCI and AUD Active, Open Label iTBS-rTMS - Alcohol Use Disorder, Mild Cognitive Impairment | Phase 1 | Active not recruiting | Medical University of South Carolina | 35 | 2023-11-01 | 2026-09-17 |
| Protecting Alzheimer Caregivers Using Technology Through Staying Sharp Staying Sharp intervention - Mild Cognitive Impairment, Dementia Alzheimers | Phase 1 / Phase 2 | Unknown | Oregon Health and Science University | 138 | 2023-04-30 | 2023-02-09 |
| Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment Continuous Glucose Monitor (CGM) - Type 2 Diabetes, Mild Cognitive Impairment | Phase 1 | Completed | NYU Langone Health | 14 | 2023-04-19 | 2026-08-27 |
| Innate Immunity Stimulation Via TLR9 in Early AD CpG1018, Placebo - Mild Cognitive Impairment, Alzheimer Dementia | Phase 1 | Recruiting | NYU Langone Health | 18 | 2023-03-13 | 2026-01-07 |
| Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants NIO752, Matching placebo - Alzheimer Disease, Mild Cognitive Impairment | Phase 1 | Active not recruiting | Novartis Pharmaceuticals | 38 | 2023-02-23 | 2026-09-18 |
| Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial Baricitinib - Amyotrophic Lateral Sclerosis, Alzheimer Disease | Phase 1 / Phase 2 | Completed | Massachusetts General Hospital | 17 | 2022-12-05 | 2026-06-30 |
| Safety and Target Engagement of Centella Asiatica in Cognitive Impairment Centella asiatica product, Placebo - Mild Cognitive Impairment, Alzheimer's Disease | Phase 1 | Recruiting | Oregon Health and Science University | 48 | 2022-12-01 | 2025-04-11 |
| Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment NITESGON, Lidocaine / Prilocaine Topical Cream, C5/C6 stimulation - Mild Cognitive Impairment, Memory Impairment | Phase 1 / Phase 2 | Completed | University of Dublin, Trinity College | 80 | 2022-09-01 | 2026-01-26 |
| ALSENLITE: Senolytics for Alzheimer's Disease Dasatinib, Quercetin - Mild Cognitive Impairment, Alzheimer Disease | Phase 1 / Phase 2 | Active not recruiting | Mayo Clinic | 20 | 2022-07-06 | 2026-07-17 |
| A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment AAV2-BDNF Gene Therapy - Alzheimer's Disease, Mild Cognitive Impairment | Phase 1 | Active not recruiting | Mark Tuszynski | 12 | 2022-02-07 | 2026-07-10 |
Showing 20 of 68. Sign in to see all of them.
Cognitive Dysfunction (68) · Alzheimer Disease (36) · Dementia (11) · Parkinson Disease (4) · Brain Diseases (2) · Central Nervous System Diseases (2) · Depression (2) · Inflammation (2) · Memory Disorders (2) · Neurodegenerative Diseases (2) · Tauopathies (2) · Alcoholism (1) · Amyotrophic Lateral Sclerosis (1) · Anxiety Disorders (1) · Autism Spectrum Disorder (1)
Cognition Disorders (68) · Mental Disorders (68) · Neurocognitive Disorders (67) · Nervous System Diseases (42) · Central Nervous System Diseases (40) · Brain Diseases (39) · Neurodegenerative Diseases (35) · Tauopathies (34) · Dementia (29) · Behavior (5) · Pathological Conditions, Signs and Symptoms (5) · Basal Ganglia Diseases (4) · Movement Disorders (4) · Neurobehavioral Manifestations (4) · Neurologic Manifestations (4)
Donepezil (3) · 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene (2) · Transcranial Direct Current Stimulation (2) · (11C)-MC1 (1) · 1018 oligonucleotide (1) · 11C-PS13 (1) · 2-(aminomethyl)phenol (1) · 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1) · Administration, Sublingual (1) · Anesthetics, Local (1) · Brain-Computer Interfaces (1) · Dabigatran (1) · Dasatinib (1) · Drug Evaluation (1) · Emtricitabine (1)
Massachusetts General Hospital (3) · Mayo Clinic (3) · Merck Sharp & Dohme LLC (2) · NYU Langone Health (2) · National Institute of Mental Health (NIMH) (2) · Oregon Health and Science University (2) · Seoul National University Bundang Hospital (2) · University of California, Los Angeles (2) · VA Office of Research and Development (2) · AC Immune SA (1) · AbbVie (1) · Actinogen Medical (1) · Adeona Pharmaceuticals (1) · Avid Radiopharmaceuticals (1) · Biomind Labs Inc. (1)
United States (40) · Canada (4) · Australia (3) · Netherlands (3) · Finland (2) · France (2) · Israel (2) · Singapore (2) · Sweden (2) · United Kingdom (2) · Argentina (1) · Brazil (1) · China (1) · Ireland (1) · Italy (1)
Alexander C Conley, PhD (1) · Amala Soumyanath, Ph.D (1) · Arjun Masurkar, MD (1) · Barry Halliwell (1) · Benjamin M. Hampstead, PhD (1) · Chao-Yi Wu, PhD (1) · Christopher Chen (1) · Christopher R Martens, Ph.D. (1) · Daniel H. Silverman, MD, Ph.D. (1) · David M Burger, PharmD, PhD (1) · David Newsome, M.D. (1) · David Q Beversdorf, MD (1)
PMID 19198615, PMID 19812460, PMID 21358740, PMID 22172392, PMID 22252372, PMID 22409311, PMID 22986776, PMID 23152610, PMID 23300829, PMID 24068826, PMID 24260218, PMID 26302439, PMID 30052328, PMID 31424410, PMID 33344752, PMID 34366147, PMID 34570177, PMID 34670118, PMID 36117569, PMID 36170815, PMID 39422960, PMID 39542698, PMID 39544014, PMID 39760921, PMID 40009460, PMID 40368603, PMID 41225155, PMID 42083927, PMID 42372258, PMID 42382101, PMID 42791030
2018 (2), 1UF1AG046148 (1), 2017 (1), IK2RX002938 (1), K01AG054731 (1), P30AG024978 (1), P50AA010761 (1), P50AG005136 (1), R01AG060981 (1), R01AG090377 (1), R61AG085253 (1)